Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 known ✓ | P23975 | 7/20 | 0.43 |
| ▸ | SLC6A4 known ✓ | P31645 | 5/20 | 0.43 |
| ▸ | SLC6A3 known ✓ | Q01959 | 5/20 | 0.43 |
| ▸ | KCNH2 known ✓ | Q12809 | 3/20 | 0.43 |
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A known ✓ | Q03164 | 1/20 | 0.36 |
| ▸ | HRH1 known ✓ | P35367 | 3/20 | 0.36 |
| ▸ | CHRM3 known ✓ | P20309 | 4/20 | 0.36 |
| ▸ | CHRM2 known ✓ | P08172 | 3/20 | 0.36 |
| ▸ | HTR1A known ✓ | P08908 | 1/20 | 0.35 |
| ▸ | LPL | P06858 | 1/20 | 0.38 |
| ▸ | LIPC | P11150 | 1/20 | 0.38 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.38 |
| ▸ | F10 | P00742 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.36 |
| ▸ | BCL9 | O00512 | 2/20 | 0.35 |
| ▸ | CTNNB1 | P35222 | 2/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL4137006 | 1.00 | SLC6A2 (0.43) | SLC6A2SLC6A4SLC6A3KCNH2LPL | |
| Fumaric Acid SCHEMBL4136998 | 1.00 | SLC6A2 (0.43) | SLC6A2SLC6A4SLC6A3KCNH2LPL | |
| SCHEMBL4131295 | 0.91 | SLC6A2 (0.50) | SLC6A2SLC6A4SLC6A3KCNH2F10 | |
| SCHEMBL4131300 | 0.91 | SLC6A2 (0.50) | SLC6A2SLC6A4SLC6A3KCNH2F10 | |
| Fumaric Acid SCHEMBL4138919 | 0.81 | SLC6A2 (0.42) | SLC6A2SLC6A4SLC6A3KCNH2F10 | |
| Fumaric Acid SCHEMBL4138921 | 0.81 | SLC6A2 (0.42) | SLC6A2SLC6A4SLC6A3KCNH2F10 | |
| Fumaric Acid SCHEMBL4138909 | 0.81 | SLC6A2 (0.42) | SLC6A2SLC6A4SLC6A3KCNH2F10 | |
| Fumaric Acid SCHEMBL4139366 | 0.79 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3KCNH2F10 | |
| Fumaric Acid SCHEMBL4139372 | 0.79 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3KCNH2F10 | |
| Fumaric Acid SCHEMBL4139373 | 0.79 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3KCNH2F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090215857-A1 | Therapeutic Pyrrolidines | PFIZER PRODUCTS INC. (US) | 2009-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215857-A1 | Therapeutic Pyrrolidines | OPRL1, HTR5A, OPRD1 | SLC6A2 28/4885SLC6A4 18/4885SLC6A3 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.